TD Cowen on Novartis (NVS): 'Meetings With Management Highlight Multiple Drivers Of Business Momentum'

November 10, 2025 8:36 AM EST Send to a Friend
TD Cowen analyst Steve Scala reiterated a Hold rating and $140.00 price target on Novartis (NYSE: NVS).The analyst commented: "Meetings ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login